<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25960" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nonketotic Hyperglycinemia</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Krawiec</surname>
            <given-names>Conrad</given-names>
          </name>
          <aff>Penn State College of Medicine</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Anastasopoulou</surname>
            <given-names>Catherine</given-names>
          </name>
          <aff>Jefferson Einstein Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Conrad Krawiec declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Catherine Anastasopoulou declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>2</day>
          <month>3</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25960.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Nonketotic hyperglycinemia is a rare, genetic, inborn error of glycine metabolism. Due to a mutation in the glycine cleavage enzyme system, the patient is unable to break down glycine, resulting in its accumulation throughout the body. The buildup of glycine primarily occurs within the spinal cord and brain; thus, the initial clinical manifestations and long-term sequelae from this condition are often neurological. No known interventions are effective in altering the natural history of nonketotic hyperglycinemia, but whatever therapeutic strategies are applied can potentially reduce the comorbidities associated with this condition. It is essential that the clinician recognizes this disease and initiates early evaluation and treatment to attain the best possible outcome. This activity reviews the assessment and management of nonketotic hyperglycinemia and highlights the interprofessional healthcare team's role in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of nonketotic hyperglycinemia.</p></list-item><list-item><p>Outline the appropriate evaluation of a patient with nonketotic hyperglycinemia.</p></list-item><list-item><p>Review the management options available for nonketotic hyperglycinemia.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to manage nonketotic hyperglycinemia and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25960&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25960">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-25960.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nonketotic hyperglycinemia (NKH) is a rare genetic disease secondary to an inborn error of glycine metabolism.<xref ref-type="bibr" rid="article-25960.r1">[1]</xref> Due to a mutation in the glycine cleavage enzyme system, the patient is unable to break down glycine, ultimately resulting in its accumulation throughout the body.<xref ref-type="bibr" rid="article-25960.r2">[2]</xref><xref ref-type="bibr" rid="article-25960.r3">[3]</xref><xref ref-type="bibr" rid="article-25960.r4">[4]</xref>&#x000a0;The buildup of glycine primarily occurs within the spinal cord and brain; thus, the initial clinical manifestations and the long-term sequelae from this condition are more often of neurological origin.<xref ref-type="bibr" rid="article-25960.r1">[1]</xref><xref ref-type="bibr" rid="article-25960.r2">[2]</xref><xref ref-type="bibr" rid="article-25960.r5">[5]</xref>&#x000a0;</p>
        <p>No known interventions are effective in altering the natural history of nonketotic hyperglycinemia, but whatever therapeutic strategies are applied can potentially reduce the comorbidities associated with this condition. It is essential that the clinician recognizes this disease and initiates early evaluation and treatment to attain the best possible outcome.<xref ref-type="bibr" rid="article-25960.r4">[4]</xref></p>
      </sec>
      <sec id="article-25960.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Classic nonketotic hyperglycinemia commonly occurs due to defects in the genes (GLDC and AMT) that encode the protein components of the glycine cleavage enzyme system resulting in decreased enzyme activity.<xref ref-type="bibr" rid="article-25960.r6">[6]</xref></p>
        <p>Newer mutations were also reported in recent studies from Chinese&#x000a0;and Turkish patients.<xref ref-type="bibr" rid="article-25960.r7">[7]</xref> This is an autosomal recessive hereditary disease that usually presents at a very early age.&#x000a0;</p>
      </sec>
      <sec id="article-25960.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Classic nonketotic hyperglycinemia is a rare disorder with a global incidence of 1&#x000a0;in 76,000.<xref ref-type="bibr" rid="article-25960.r8">[8]</xref> The incidence may range between 1&#x000a0;in 12,000 to 1&#x000a0;in 63,000 cases in newborn babies in certain geographic areas.<xref ref-type="bibr" rid="article-25960.r9">[9]</xref><xref ref-type="bibr" rid="article-25960.r10">[10]</xref>&#x000a0;This disease can occur in any population, but it is reportedly seen more frequently in individuals of Finnish descent.<xref ref-type="bibr" rid="article-25960.r10">[10]</xref></p>
      </sec>
      <sec id="article-25960.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Glycine is an amino acid that is primarily&#x000a0;an inhibitory neurotransmitter but also serves as a co-agonist (excitation modulator) of N-methyl-D-aspartate (NMDA) (glutamatergic) receptors.<xref ref-type="bibr" rid="article-25960.r11">[11]</xref><xref ref-type="bibr" rid="article-25960.r12">[12]</xref> Excessive activation of N-methyl-D-aspartate&#x000a0;receptors can result in neuronal and axonal injury as well as potential impairment of neurogenesis.<xref ref-type="bibr" rid="article-25960.r13">[13]</xref><xref ref-type="bibr" rid="article-25960.r14">[14]</xref> Nonketotic hyperglycinemia occurs due to decreased activity of the glycine cleavage enzyme system, which is the system tasked with maintaining the appropriate glycine concentration.<xref ref-type="bibr" rid="article-25960.r2">[2]</xref><xref ref-type="bibr" rid="article-25960.r3">[3]</xref> This results in an accumulation of a significant quantity of glycine throughout the body, primarily within the brain and the spinal cord.<xref ref-type="bibr" rid="article-25960.r1">[1]</xref><xref ref-type="bibr" rid="article-25960.r5">[5]</xref> The pathophysiologic process of nonketotic hyperglycinemia likely begins as early in utero; thus, irreversible glycine-induced brain damage is also likely that has already occurred by the time of the patient symptom presentation.<xref ref-type="bibr" rid="article-25960.r15">[15]</xref></p>
      </sec>
      <sec id="article-25960.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>When a patient presents with signs and symptoms&#x000a0;that cause concern for an inborn error of metabolism, the usual systematic approach of good history and physical examination are required.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref> Particular historical features that the clinician should investigate for nonketotic hyperglycinemia include a past medical history and a review of systems that focus on the presence of lethargy, poor feeding, hypotonia, refractory seizures, encephalopathy (particularly if there are unexplained episodes), and apnea (if the patient presents during the neonatal period). It is essential for the clinician to fully investigate the patient's dietary history, growth, and development.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref></p>
        <p>Additional questions should focus on developmental delays (expressive language impairment), hyperactivity, and the progression of the patient's clinical manifestations as they become older children.<xref ref-type="bibr" rid="article-25960.r4">[4]</xref><xref ref-type="bibr" rid="article-25960.r16">[16]</xref>&#x000a0;It is important to review a patient's family history, particularly for any evidence of stillbirth, unexplained neonatal death, and consanguinity.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref> Nonketotic hyperglycinemia is a disorder that begins in utero and commonly presents with abnormalities that are already present at birth; thus, the maternal history should be thoroughly reviewed. Inquiries regarding fetal movement, particularly neonatal hiccups, are suspicious for nonketotic hyperglycinemia and should be asked directly.<xref ref-type="bibr" rid="article-25960.r1">[1]</xref><xref ref-type="bibr" rid="article-25960.r17">[17]</xref></p>
        <p>Physical examination findings that are suspicious for nonketotic hyperglycinemia are nonspecific but include lethargy and impaired mental status (like encephalopathy).<xref ref-type="bibr" rid="article-25960.r16">[16]</xref> A complete neurologic examination should be performed on these patients. The exam&#x000a0;should also focus on the respiratory system (evaluating for apnea, hiccuping, and/or irregular breathing, placing the patient at risk for respiratory failure), as well as a motor exam and an evaluation of muscle tone&#x000a0;since patients may be hypotonic.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref></p>
        <p>Nonketotic hyperglycinemia is divided into two forms, severe and attenuated. Patients with severe NKH usually have intractable seizures and present no developmental progress, whereas those with the attenuated form of the disease present with varied developmental progress and no epilepsy (or easily controlled seizures).<xref ref-type="bibr" rid="article-25960.r18">[18]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-25960.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>For patients with nonketotic hyperglycinemia, a systematic laboratory and diagnostic approach is often undertaken when the patient first presents, as the etiology is often unknown. This may include a CBC with differential, blood glucose, electrolytes, blood urea nitrogen, creatinine, uric acid, arterial blood gas, ammonia level, and liver enzymes.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref></p>
        <p>These tests are often followed by specialized testing in consultation with a metabolic specialist. For nonketotic hyperglycinemia, measurement of glycine within the plasma and the cerebral spinal fluid (evaluating for an abnormal CSF-to-plasma glycine ratio), a magnetic resonance imaging of the brain (evaluating for diffusion restriction in the infratentorial regions like the posterior limb of the internal capsule, anterior brain stem, posterior tegmental tracts, and cerebellum before the age of 3 months and generalized diffusion restriction of the supratentorial white matter after three months), a brain magnetic resonance spectroscopy, molecular genetic testing, and rarely, analysis of enzymatic activity should be performed, and they can help to establish the diagnosis as well as the extent of the systemic damage.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref><xref ref-type="bibr" rid="article-25960.r19">[19]</xref><xref ref-type="bibr" rid="article-25960.r20">[20]</xref>&#x000a0;</p>
        <p>If the patient has a seizure activity, additional testing may include an electroencephalogram.<xref ref-type="bibr" rid="article-25960.r16">[16]</xref></p>
      </sec>
      <sec id="article-25960.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There are no effective treatment strategies that alter the natural history of nonketotic hyperglycinemia.<xref ref-type="bibr" rid="article-25960.r1">[1]</xref><xref ref-type="bibr" rid="article-25960.r21">[21]</xref>&#x000a0;Thus, treatment focuses on reducing plasma glycine concentration by initiating sodium benzoate therapy and utilizing N-methyl-D-aspartate receptor site antagonists (i.e., dextromethorphan, oral ketamine) to reduce glycinergic stimulation.<xref ref-type="bibr" rid="article-25960.r21">[21]</xref><xref ref-type="bibr" rid="article-25960.r22">[22]</xref><xref ref-type="bibr" rid="article-25960.r23">[23]</xref>&#x000a0;These therapies have been shown to improve seizure control and neurodevelopmental outcomes in selected populations with nonketotic hyperglycinemia.<xref ref-type="bibr" rid="article-25960.r4">[4]</xref></p>
        <p>After establishing the diagnosis of nonketotic hyperglycinemia, the patient will require routine developmental assessments, frequent orthopedic evaluation for scoliosis and hip dislocation, especially as they age, and routine ophthalmologic evaluation to determine the presence of cortical blindness.<xref ref-type="bibr" rid="article-25960.r24">[24]</xref><xref ref-type="bibr" rid="article-25960.r25">[25]</xref><xref ref-type="bibr" rid="article-25960.r26">[26]</xref>&#x000a0;The patient may develop pulmonary hypertension, thus requiring&#x000a0;cardiology evaluation to determine if they would benefit from pharmacological therapy.<xref ref-type="bibr" rid="article-25960.r27">[27]</xref><xref ref-type="bibr" rid="article-25960.r28">[28]</xref>&#x000a0;A gastrointestinal referral may be necessary to determine if enteral access is needed for nutrition.<xref ref-type="bibr" rid="article-25960.r24">[24]</xref>&#x000a0;These patients&#x000a0;often require long-term antiepileptic maintenance therapy with antiepileptic therapy, diet, and special surgical interventions (like vagal nerve stimulator placement).<xref ref-type="bibr" rid="article-25960.r27">[27]</xref></p>
      </sec>
      <sec id="article-25960.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The clinical manifestations guide the differential diagnosis of this condition during the presentation. Inborn errors of metabolism do not represent the most common cause of confirmed seizures or encephalopathy. Thus, the clinician should first consider acute metabolic disturbances (for example, hypoglycemia), hypoxia, intracranial hemorrhage, sepsis, thrombosis, neonatal epilepsy syndromes, or congenital brain malformations.<xref ref-type="bibr" rid="article-25960.r29">[29]</xref><xref ref-type="bibr" rid="article-25960.r30">[30]</xref><xref ref-type="bibr" rid="article-25960.r31">[31]</xref><xref ref-type="bibr" rid="article-25960.r32">[32]</xref><xref ref-type="bibr" rid="article-25960.r33">[33]</xref></p>
        <p>During the newborn screening, or when a clinician suspects an inborn error of metabolism, laboratory features of nonketotic hyperglycinemia may be present. The following conditions, therefore, must be differentiated from nonketotic hyperglycinemia. These include:</p>
        <list list-type="order">
          <list-item>
            <p>Medications (particularly valproate, which is known to decrease glycine cleavage enzyme system activity)<xref ref-type="bibr" rid="article-25960.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Artificial elevation due to&#x000a0;laboratory sampling technique<xref ref-type="bibr" rid="article-25960.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Starvation<xref ref-type="bibr" rid="article-25960.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Use of&#x000a0;glycine-containing fluids (i.e., bladder irrigation fluid)<xref ref-type="bibr" rid="article-25960.r34">[34]</xref></p>
          </list-item>
          <list-item>
            <p>Transient glycine encephalopathy due to intracerebral hemorrhage or hypoxic-ischemic injury<xref ref-type="bibr" rid="article-25960.r34">[34]</xref><xref ref-type="bibr" rid="article-25960.r35">[35]</xref></p>
          </list-item>
          <list-item>
            <p>Transient glycine encephalopathy due to immaturity of the glycine cleavage enzyme system<xref ref-type="bibr" rid="article-25960.r36">[36]</xref></p>
          </list-item>
          <list-item>
            <p>Hyperglycinuria (due to defects in the renal transport of glycine, including familial iminoglycinuria or benign hyperglycinuria)<xref ref-type="bibr" rid="article-25960.r34">[34]</xref></p>
          </list-item>
        </list>
        <p>There are inherited metabolic conditions that resemble nonketotic hyperglycinemia, but they have different pathophysiologic mechanisms, and they may require different treatment strategies. These include:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Organic acidurias<xref ref-type="bibr" rid="article-25960.r37">[37]</xref></p>
          </list-item>
          <list-item>
            <p>Pyridoxine dependent epilepsy<xref ref-type="bibr" rid="article-25960.r38">[38]</xref></p>
          </list-item>
          <list-item>
            <p>Disorders of intracellular cobalamin metabolism<xref ref-type="bibr" rid="article-25960.r39">[39]</xref></p>
          </list-item>
          <list-item>
            <p>GLYT1 encephalopathy<xref ref-type="bibr" rid="article-25960.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Lipoate deficiency<xref ref-type="bibr" rid="article-25960.r41">[41]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25960.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis&#x000a0;depends on the amount of glycine cleavage enzyme system activity.<xref ref-type="bibr" rid="article-25960.r42">[42]</xref>&#x000a0;Severe deficiency in this enzyme results in the presentation of the disease during the neonatal period, which is associated with a poor prognosis due to life-threatening apnea.<xref ref-type="bibr" rid="article-25960.r42">[42]</xref><xref ref-type="bibr" rid="article-25960.r43">[43]</xref> In neonates where spontaneous breathing is reestablished, these patients may develop&#x000a0;progressive lethargy, encephalopathy, or death.&#x000a0;Other patients might be marred by a lifetime of severe developmental impairment and intractable epilepsy.<xref ref-type="bibr" rid="article-25960.r44">[44]</xref><xref ref-type="bibr" rid="article-25960.r45">[45]</xref>&#x000a0;Patients who present later in life (defined as three months or later) are more likely to have attenuated glycine cleavage enzyme activity.<xref ref-type="bibr" rid="article-25960.r42">[42]</xref>&#x000a0;In those patients, the developmental progress and severity of epilepsy may vary depending on when the disease is recognized and if early treatment is initiated.<xref ref-type="bibr" rid="article-25960.r4">[4]</xref><xref ref-type="bibr" rid="article-25960.r46">[46]</xref></p>
      </sec>
      <sec id="article-25960.s11" sec-type="Complications">
        <title>Complications</title>
        <p>When this disease presents in neonates, the patient may develop severe apnea resulting in acute hypoxemic respiratory failure requiring respiratory support.<xref ref-type="bibr" rid="article-25960.r42">[42]</xref><xref ref-type="bibr" rid="article-25960.r44">[44]</xref> In patients where respiratory failure resolves, the patient might likely develop progressive lethargy or encephalopathy. Some patients may live for several years, though death can occur at any time, depending on the severity of the disease.<xref ref-type="bibr" rid="article-25960.r28">[28]</xref><xref ref-type="bibr" rid="article-25960.r42">[42]</xref><xref ref-type="bibr" rid="article-25960.r44">[44]</xref>&#x000a0;</p>
        <p>In those patients that survive or present later in life (mostly at three months or later), the severity of the disease varies.<xref ref-type="bibr" rid="article-25960.r42">[42]</xref><xref ref-type="bibr" rid="article-25960.r44">[44]</xref> They may be marred by a lifetime of no or limited developmental progress, intractable epilepsy, pulmonary hypertension, dysphagia&#x000a0;and gastrointestinal dysmotility requiring surgical enteral access, scoliosis, hip dislocation due to spasticity, and even cortical blindness.<xref ref-type="bibr" rid="article-25960.r24">[24]</xref><xref ref-type="bibr" rid="article-25960.r25">[25]</xref><xref ref-type="bibr" rid="article-25960.r27">[27]</xref><xref ref-type="bibr" rid="article-25960.r28">[28]</xref>&#x000a0;Different studies in infants also reported the presence of hydrocephalus&#x000a0;<xref ref-type="bibr" rid="article-25960.r47">[47]</xref>&#x000a0;that required shunt placement.</p>
      </sec>
      <sec id="article-25960.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>After the diagnosis of NKH has been made, most patients will benefit from evaluations by different specialists, including but not limited to a neurologist, a pulmonologist, a gastroenterologist, an orthopedic surgeon, and an ophthalmologist. Genetic counseling is essential in an effort also to help the families that have to take care of these patients. In the long run, for patients that survive, physical medicine and rehabilitation specialists should also be consulted to help with recovery from complications and, in particular physical disability, if any. Due to the need for multiple medical services, these patients will benefit from dedicated nursing teams and also social workers who can coordinate the care and alleviate some of the burden from parents and families.</p>
      </sec>
      <sec id="article-25960.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Parents should be counseled on the prognosis of nonketotic hyperglycinemia, particularly the possibility of neurologic impairments in those who survive.<xref ref-type="bibr" rid="article-25960.r28">[28]</xref>&#x000a0;In patients who develop long-term epilepsy, the parents should have higher vigilance in situations (i.e., ensure adequate supervision) where the dangers can be compounded if seizure activity occurs.<xref ref-type="bibr" rid="article-25960.r48">[48]</xref>&#x000a0;</p>
        <p>Genetic counseling may be required to help parents and siblings of a child with nonketotic hyperglycinemia understand the genetic risks to help them make informed future medical and personal decisions.<xref ref-type="bibr" rid="article-25960.r49">[49]</xref></p>
      </sec>
      <sec id="article-25960.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Diagnosing and managing nonketotic hyperglycinemia require an interprofessional team approach that includes clinicians (including mid-level practitioners), nursing staff, and pharmacists to avoid complications like underrecognition of clinical seizures and ensure that early and proper diagnostic testing is performed.&#x000a0;Referral to critical care services (neonatal or pediatric) should be performed early to place the patient under the care of neurocritical care experts and to ensure that the patient is stabilized from a neurocritical care standpoint.<xref ref-type="bibr" rid="article-25960.r50">[50]</xref> [Level 4] Specialists involved in the care of these patients may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>The pediatric neurologist should be consulted to evaluate the patient and confirm the diagnosis of seizures.<xref ref-type="bibr" rid="article-25960.r50">[50]</xref> [Level 4]</p>
          </list-item>
          <list-item>
            <p>A metabolic specialist should be consulted to ensure that the patient receives an appropriate evaluation and initiation of therapy.<xref ref-type="bibr" rid="article-25960.r51">[51]</xref> [Level 4]</p>
          </list-item>
          <list-item>
            <p>Genetic counseling specialists that the patient&#x02019;s parents should be referred to determine the genetic risk for medical and personal reasons.<xref ref-type="bibr" rid="article-25960.r49">[49]</xref> [Level 4]</p>
          </list-item>
          <list-item>
            <p>Pediatric palliative care specialists should be consulted in cases of patients with severe nonketotic hyperglycinemia, as these children have a poor neurologic prognosis, and families might need to get help for a difficult decision to be made about withdrawing critical care support.<xref ref-type="bibr" rid="article-25960.r28">[28]</xref> [Level 4]&#x000a0;</p>
          </list-item>
        </list>
        <p>Nurses will be crucial in coordinating care between the various clinicians. In cases where anti-epileptic medications are necessary, the pharmacist will consult with clinicians to determine optimal dosing and agent selection and perform medication reconciliation. With this integrated and interprofessional coordination, timely and directed care coordination can improve patient outcomes. [Level 5]</p>
      </sec>
      <sec id="article-25960.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25960&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25960">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/genetic-disorders/nonketotic-hyperglycinemia/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=25960">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25960/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25960">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-25960.s16">
        <title>References</title>
        <ref id="article-25960.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iqbal</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mordekar</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic hyperglycinemia case series.</article-title>
            <source>J Pediatr Neurosci</source>
            <year>2015</year>
            <season>Oct-Dec</season>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>355</fpage>
            <page-range>355-8</page-range>
            <pub-id pub-id-type="pmid">26962342</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poothrikovil</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Al Thihli</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Al Futaisi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Al Murshidi</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic Hyperglycinemia: Two Case Reports and Review.</article-title>
            <source>Neurodiagn J</source>
            <year>2019</year>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>142</fpage>
            <page-range>142-151</page-range>
            <pub-id pub-id-type="pmid">31433733</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tada</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Narisawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Konno</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yokoyama</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Hyperglycinemia: a defect in glycine cleavage reaction.</article-title>
            <source>Tohoku J Exp Med</source>
            <year>1969</year>
            <month>Jul</month>
            <volume>98</volume>
            <issue>3</issue>
            <fpage>289</fpage>
            <page-range>289-96</page-range>
            <pub-id pub-id-type="pmid">5307488</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bjoraker</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Fergeson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dyack</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Friederich</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Creadon-Swindell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Gaughan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burns</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Neurodevelopmental Outcome and Treatment Efficacy of Benzoate and Dextromethorphan in Siblings with Attenuated Nonketotic Hyperglycinemia.</article-title>
            <source>J Pediatr</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>170</volume>
            <fpage>234</fpage>
            <page-range>234-9</page-range>
            <pub-id pub-id-type="pmid">26749113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Mankad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kinali</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>AP</given-names>
              </name>
            </person-group>
            <article-title>Neuroimaging Spectrum of Inherited Neurotransmitter Disorders.</article-title>
            <source>Neuropediatrics</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>51</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-21</page-range>
            <pub-id pub-id-type="pmid">31634934</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kure</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dinopoulos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gail</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>DeGrauw</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bzduch</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kalmanchey</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fekete</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Trojovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Plecko</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Breningstall</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tohyama</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsubara</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Comprehensive mutation analysis of GLDC, AMT, and GCSH in nonketotic hyperglycinemia.</article-title>
            <source>Hum Mutat</source>
            <year>2006</year>
            <month>Apr</month>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>343</fpage>
            <page-range>343-52</page-range>
            <pub-id pub-id-type="pmid">16450403</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ning</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>SQ</given-names>
              </name>
            </person-group>
            <article-title>Clinical and genetic analysis of nonketotic hyperglycinemia: A case report.</article-title>
            <source>World J Clin Cases</source>
            <year>2022</year>
            <month>Aug</month>
            <day>06</day>
            <volume>10</volume>
            <issue>22</issue>
            <fpage>7982</fpage>
            <page-range>7982-7988</page-range>
            <pub-id pub-id-type="pmid">36158497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Kronquist</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Acquaviva</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hutchin</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Pombo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>V&#x000e4;is&#x000e4;nen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Creadon-Swindell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Br&#x000e1;s-Goldberg</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Rahikkala</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Moilanen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Mahieu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Matthijs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bravo-Alonso</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>P&#x000e9;rez-Cerd&#x000e1;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ugarte</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vianey-Saban</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Scharer</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>The genetic basis of classic nonketotic hyperglycinemia due to mutations in GLDC and AMT.</article-title>
            <source>Genet Med</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>104</fpage>
            <page-range>104-111</page-range>
            <pub-id pub-id-type="pmid">27362913</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Applegarth</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Toone</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lowry</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Incidence of inborn errors of metabolism in British Columbia, 1969-1996.</article-title>
            <source>Pediatrics</source>
            <year>2000</year>
            <month>Jan</month>
            <volume>105</volume>
            <issue>1</issue>
            <fpage>e10</fpage>
            <pub-id pub-id-type="pmid">10617747</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>von Wendt</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hirvasniemi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Simil&#x000e4;</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic hyperglycinemia. A genetic study of 13 Finnish families.</article-title>
            <source>Clin Genet</source>
            <year>1979</year>
            <month>May</month>
            <volume>15</volume>
            <issue>5</issue>
            <fpage>411</fpage>
            <page-range>411-7</page-range>
            <pub-id pub-id-type="pmid">445864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Okuro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karakawa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuneyoshi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawasaki</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bannai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nishino</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus.</article-title>
            <source>Neuropsychopharmacology</source>
            <year>2015</year>
            <month>May</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>1405</fpage>
            <page-range>1405-16</page-range>
            <pub-id pub-id-type="pmid">25533534</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subramanian</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kadiyala</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hariharan</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Neeraj</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A rare case of glycine encephalopathy unveiled by valproate therapy.</article-title>
            <source>J Pediatr Neurosci</source>
            <year>2015</year>
            <season>Apr-Jun</season>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-5</page-range>
            <pub-id pub-id-type="pmid">26167219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>Excitatory amino acid neurotoxicity in the developing brain.</article-title>
            <source>NIDA Res Monogr</source>
            <year>1993</year>
            <volume>133</volume>
            <fpage>185</fpage>
            <page-range>185-205</page-range>
            <pub-id pub-id-type="pmid">8232513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McDonald</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>MV</given-names>
              </name>
            </person-group>
            <article-title>Physiological and pathophysiological roles of excitatory amino acids during central nervous system development.</article-title>
            <source>Brain Res Brain Res Rev</source>
            <year>1990</year>
            <season>Jan-Apr</season>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-70</page-range>
            <pub-id pub-id-type="pmid">2163714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korman</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Wexler</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Gutman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rolland</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Kanno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kure</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation.</article-title>
            <source>Ann Neurol</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>411</fpage>
            <page-range>411-5</page-range>
            <pub-id pub-id-type="pmid">16404748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almannai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>El-Hattab</surname>
                <given-names>AW</given-names>
              </name>
            </person-group>
            <article-title>Inborn Errors of Metabolism with Seizures: Defects of Glycine and Serine Metabolism and Cofactor-Related Disorders.</article-title>
            <source>Pediatr Clin North Am</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>279</fpage>
            <page-range>279-299</page-range>
            <pub-id pub-id-type="pmid">29502914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alfadhel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nashabat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Qahtani</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Alfares</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mutairi</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Shaalan</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Douglas</surname>
                <given-names>GV</given-names>
              </name>
              <name>
                <surname>Wierenga</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Juusola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Alrifai</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Arold</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Alkuraya</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>QA</given-names>
              </name>
            </person-group>
            <article-title>Mutation in SLC6A9 encoding a glycine transporter causes a novel form of non-ketotic hyperglycinemia in humans.</article-title>
            <source>Hum Genet</source>
            <year>2016</year>
            <month>Nov</month>
            <volume>135</volume>
            <issue>11</issue>
            <fpage>1263</fpage>
            <page-range>1263-1268</page-range>
            <pub-id pub-id-type="pmid">27481395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Van Hove</surname>
                <given-names>JLK</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hennermann</surname>
                <given-names>JB</given-names>
              </name>
            </person-group>
            <chapter-title>Nonketotic Hyperglycinemia</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2002</year>
            <month>11</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">20301531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stence</surname>
                <given-names>NV</given-names>
              </name>
              <name>
                <surname>Fenton</surname>
                <given-names>LZ</given-names>
              </name>
              <name>
                <surname>Levek</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Hennermann</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Wortmann</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JLK</given-names>
              </name>
            </person-group>
            <article-title>Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2019</year>
            <month>May</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>438</fpage>
            <page-range>438-450</page-range>
            <pub-id pub-id-type="pmid">30737808</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Karnebeek</surname>
                <given-names>CDM</given-names>
              </name>
              <name>
                <surname>Sayson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JJY</given-names>
              </name>
              <name>
                <surname>Tseng</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Blau</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Horvath</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Metabolic Evaluation of Epilepsy: A Diagnostic Algorithm With Focus on Treatable Conditions.</article-title>
            <source>Front Neurol</source>
            <year>2018</year>
            <volume>9</volume>
            <fpage>1016</fpage>
            <pub-id pub-id-type="pmid">30559706</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Vande Kerckhove</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hennermann</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Mahieu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Declercq</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mertens</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Becker</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kishnani</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Jaeken</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2005</year>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>651</fpage>
            <page-range>651-63</page-range>
            <pub-id pub-id-type="pmid">16151895</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alemzadeh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gammeltoft</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Matteson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of low-dose dextromethorphan in the treatment of nonketotic hyperglycinemia.</article-title>
            <source>Pediatrics</source>
            <year>1996</year>
            <month>Jun</month>
            <volume>97</volume>
            <issue>6 Pt 1</issue>
            <fpage>924</fpage>
            <page-range>924-6</page-range>
            <pub-id pub-id-type="pmid">8657542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nowak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chuchra</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paprocka</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic Hyperglycinemia: Insight into Current Therapies.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>May</month>
            <day>27</day>
            <volume>11</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">35683414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramirez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Flynn</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Casalduc</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cornier</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Carlo</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Musculoskeletal manifestations of neonatal nonketotic hyperglycinemia.</article-title>
            <source>J Child Orthop</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>6</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-203</page-range>
            <pub-id pub-id-type="pmid">23814620</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markand</surname>
                <given-names>ON</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>IK</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic hyperglycinemia: electroencephalographic and evoked potential abnormalities.</article-title>
            <source>Neurology</source>
            <year>1982</year>
            <month>Feb</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-6</page-range>
            <pub-id pub-id-type="pmid">6798489</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brazis</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Graff-Radford</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>NP</given-names>
              </name>
              <name>
                <surname>Eggenberger</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Homonymous visual field defects in patients without corresponding structural lesions on neuroimaging.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2000</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>92</fpage>
            <page-range>92-6</page-range>
            <pub-id pub-id-type="pmid">10870920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cataltepe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Marter</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Kozakewich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wessel</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Pulmonary hypertension associated with nonketotic hyperglycinaemia.</article-title>
            <source>J Inherit Metab Dis</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>2</issue>
            <fpage>137</fpage>
            <page-range>137-44</page-range>
            <pub-id pub-id-type="pmid">10801055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boneh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Allan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mendelson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Spriggs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gillam</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Clinical, ethical and legal considerations in the treatment of newborns with non-ketotic hyperglycinaemia.</article-title>
            <source>Mol Genet Metab</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>94</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-7</page-range>
            <pub-id pub-id-type="pmid">18395481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Acute symptomatic seizures in term neonates: Etiologies and treatments.</article-title>
            <source>Semin Fetal Neonatal Med</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>183</fpage>
            <page-range>183-190</page-range>
            <pub-id pub-id-type="pmid">29433814</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Glidden</surname>
                <given-names>DV</given-names>
              </name>
              <name>
                <surname>Bonifacio</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Silverstein</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
              <collab>Neonatal Seizure Registry Study Group</collab>
            </person-group>
            <article-title>Contemporary Profile of Seizures in Neonates: A Prospective Cohort Study.</article-title>
            <source>J Pediatr</source>
            <year>2016</year>
            <month>Jul</month>
            <volume>174</volume>
            <fpage>98</fpage>
            <page-range>98-103.e1</page-range>
            <pub-id pub-id-type="pmid">27106855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Govaert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ramenghi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Taal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Deveber</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of perinatal stroke I: definitions, differential diagnosis and registration.</article-title>
            <source>Acta Paediatr</source>
            <year>2009</year>
            <month>Oct</month>
            <volume>98</volume>
            <issue>10</issue>
            <fpage>1556</fpage>
            <page-range>1556-67</page-range>
            <pub-id pub-id-type="pmid">19663912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamamoto</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Epilepsies and epileptic syndromes starting in the neonatal period.</article-title>
            <source>Brain Dev</source>
            <year>2011</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>213</fpage>
            <page-range>213-20</page-range>
            <pub-id pub-id-type="pmid">21067877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shellhaas</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wusthoff</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Tsuchida</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Glass</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Massey</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Soul</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wiwattanadittakun</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Abend</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Cilio</surname>
                <given-names>MR</given-names>
              </name>
              <collab>Neonatal Seizure Registry</collab>
            </person-group>
            <article-title>Profile of neonatal epilepsies: Characteristics of a prospective US cohort.</article-title>
            <source>Neurology</source>
            <year>2017</year>
            <month>Aug</month>
            <day>29</day>
            <volume>89</volume>
            <issue>9</issue>
            <fpage>893</fpage>
            <page-range>893-899</page-range>
            <pub-id pub-id-type="pmid">28733343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korman</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Gutman</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pitfalls in the diagnosis of glycine encephalopathy (non-ketotic hyperglycinemia).</article-title>
            <source>Dev Med Child Neurol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>44</volume>
            <issue>10</issue>
            <fpage>712</fpage>
            <page-range>712-20</page-range>
            <pub-id pub-id-type="pmid">12418798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aburahma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Khassawneh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Griebel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gibson</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy.</article-title>
            <source>J Child Neurol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>703</fpage>
            <page-range>703-6</page-range>
            <pub-id pub-id-type="pmid">21335543</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aliefendio&#x0011f;lu</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tana Aslan</surname>
                <given-names>Ay</given-names>
              </name>
              <name>
                <surname>Co&#x0015f;kun</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Dursun</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cakmak</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Kesimer</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Transient nonketotic hyperglycinemia: two case reports and literature review.</article-title>
            <source>Pediatr Neurol</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>151</fpage>
            <page-range>151-5</page-range>
            <pub-id pub-id-type="pmid">12699870</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayasaka</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tada</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Effects of the metabolites of the branched-chain amino acids and cysteamine on the glycine cleavage system.</article-title>
            <source>Biochem Int</source>
            <year>1983</year>
            <month>Feb</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>225</fpage>
            <page-range>225-30</page-range>
            <pub-id pub-id-type="pmid">6679320</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maeda</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inutsuka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxine-dependent seizures.</article-title>
            <source>Pediatr Neurol</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-7</page-range>
            <pub-id pub-id-type="pmid">10734255</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scalais</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Osterheld</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Weitzel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Meirleir</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mataigne</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Martens</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Friederich</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Scharer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Helbling</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wendt-Andrae</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JLK</given-names>
              </name>
            </person-group>
            <article-title>X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic Acid.</article-title>
            <source>Pediatr Neurol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>71</volume>
            <fpage>65</fpage>
            <page-range>65-69</page-range>
            <pub-id pub-id-type="pmid">28363510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alfallaj</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alfadhel</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Glycine Transporter 1 Encephalopathy From Biochemical Pathway to Clinical Disease: Review.</article-title>
            <source>Child Neurol Open</source>
            <year>2019</year>
            <volume>6</volume>
            <fpage>2329048X19831486</fpage>
            <pub-id pub-id-type="pmid">30815509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Friederich</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Swanson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Scharer</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Aicher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Creadon-Swindell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Geiger</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>MacLean</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Deshpande</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Freckmann</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Shih</surname>
                <given-names>LY</given-names>
              </name>
              <name>
                <surname>Wasserstein</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Lund</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Procopis</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cameron</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Compton</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Dieckmann</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Collard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wempe</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5.</article-title>
            <source>Brain</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>137</volume>
            <issue>Pt 2</issue>
            <fpage>366</fpage>
            <page-range>366-79</page-range>
            <pub-id pub-id-type="pmid">24334290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Swanson</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Coughlin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Scharer</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Szerlong</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Bjoraker</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Spector</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Creadon-Swindell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mahieu</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Matthijs</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hennermann</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Applegarth</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Toone</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.</article-title>
            <source>Ann Neurol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>78</volume>
            <issue>4</issue>
            <fpage>606</fpage>
            <page-range>606-18</page-range>
            <pub-id pub-id-type="pmid">26179960</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chien</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>Hwu</surname>
                <given-names>WL</given-names>
              </name>
            </person-group>
            <article-title>Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan.</article-title>
            <source>J Child Neurol</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-42</page-range>
            <pub-id pub-id-type="pmid">15032382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kure</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oota</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hino</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fukuda</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic hyperglycinemia: proposal of a diagnostic and treatment strategy.</article-title>
            <source>Pediatr Neurol</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>221</fpage>
            <page-range>221-4</page-range>
            <pub-id pub-id-type="pmid">20691948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cusmai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinelli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Moavero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dionisi Vici</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vigevano</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Castana</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Elia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernabei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bevivino</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet in early myoclonic encephalopathy due to non ketotic hyperglycinemia.</article-title>
            <source>Eur J Paediatr Neurol</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>16</volume>
            <issue>5</issue>
            <fpage>509</fpage>
            <page-range>509-13</page-range>
            <pub-id pub-id-type="pmid">22261077</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kuseyri H&#x000fc;bschmann</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Juli&#x000e1;-Palacios</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Olivella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guder</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zafeiriou</surname>
                <given-names>DI</given-names>
              </name>
              <name>
                <surname>Horvath</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kulh&#x000e1;nek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pearson</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Kuster</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cort&#x000e8;s-Saladelafont</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ib&#x000e1;&#x000f1;ez</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Jim&#x000e9;nez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Honz&#x000ed;k</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Santer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jeltsch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Garbade</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Opladen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Garc&#x000ed;a-Cazorla</surname>
                <given-names>&#x000c1;</given-names>
              </name>
            </person-group>
            <article-title>Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia.</article-title>
            <source>Ann Neurol</source>
            <year>2022</year>
            <month>Aug</month>
            <volume>92</volume>
            <issue>2</issue>
            <fpage>292</fpage>
            <page-range>292-303</page-range>
            <pub-id pub-id-type="pmid">35616651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Hove</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Kishnani</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Demaerel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kahler</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jaeken</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rutledge</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Acute hydrocephalus in nonketotic hyperglycinemia.</article-title>
            <source>Neurology</source>
            <year>2000</year>
            <month>Feb</month>
            <day>08</day>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>754</fpage>
            <page-range>754-6</page-range>
            <pub-id pub-id-type="pmid">10680820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Howard</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Radloff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sevier</surname>
                <given-names>TL</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy and sports participation.</article-title>
            <source>Curr Sports Med Rep</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>3</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-9</page-range>
            <pub-id pub-id-type="pmid">14728909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ver&#x000ed;ssimo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sim&#x000f5;es</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Robalo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Henriques</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Diogo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Grazina</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Nonketotic hyperglycinemia: a cause of encephalopathy in children.</article-title>
            <source>J Child Neurol</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>251</fpage>
            <page-range>251-4</page-range>
            <pub-id pub-id-type="pmid">22532538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mulkey</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Swearingen</surname>
                <given-names>CJ</given-names>
              </name>
            </person-group>
            <article-title>Advancing neurologic care in the neonatal intensive care unit with a neonatal neurologist.</article-title>
            <source>J Child Neurol</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>31</fpage>
            <page-range>31-5</page-range>
            <pub-id pub-id-type="pmid">23271754</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25960.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prasad</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches.</article-title>
            <source>Int J Mol Sci</source>
            <year>2017</year>
            <month>Jul</month>
            <day>02</day>
            <volume>18</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">28671587</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
